Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy

Overview of attention for article published in World Journal of Urology, February 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Oncolytic virus for expression of immune checkpoint modulators

Grant US-11779619-B2

United States of America

Combination of oncolytic virus with immune checkpoint modulators

Grant US-10765710-B2

United States of America

Oncolytic virus for expression of immune checkpoint modulators

Grant US-10555981-B2

United States of America

COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS

Application WO-2016009017-A1

World Intellectual Property Organisation (WIPO)